T2 Biosystems Inc. [TTOO] Stock trading around $0.13 per share: What’s Next?

T2 Biosystems Inc. [NASDAQ: TTOO] price plunged by -10.69 percent to reach at -$0.02. The company report on August 18, 2022 that T2 Biosystems to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans to present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Members of management are scheduled to present on Wednesday, August 31, 2022, at 11:30am ET.

Interested parties can access a live webcast of the presentation directly by following this link. An archived webcast of the presentation will be available on the “Investors” section of the T2 Biosystems website at https://www.t2biosystems.com/ following the event.

A sum of 34890297 shares traded at recent session while its average daily volume was at 34.99M shares. T2 Biosystems Inc. shares reached a high of $0.1435 and dropped to a low of $0.131 until finishing in the latest session at $0.13.

The one-year TTOO stock forecast points to a potential upside of 35.0. The average equity rating for TTOO stock is currently 2.30, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on T2 Biosystems Inc. [TTOO]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TTOO shares is $0.20 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TTOO stock is a recommendation set at 2.30. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Alliance Global Partners have made an estimate for T2 Biosystems Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on January 27, 2021. While these analysts kept the previous recommendation, BTIG Research raised their target price to Buy. The new note on the price target was released on October 08, 2020, representing the official price target for T2 Biosystems Inc. stock.

The Average True Range (ATR) for T2 Biosystems Inc. is set at 0.03, with the Price to Sales ratio for TTOO stock in the period of the last 12 months amounting to 1.89.

TTOO Stock Performance Analysis:

T2 Biosystems Inc. [TTOO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -31.54. With this latest performance, TTOO shares dropped by -8.01% in over the last four-week period, additionally sinking by -67.20% over the last 6 months – not to mention a drop of -84.83% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TTOO stock in for the last two-week period is set at 43.90, with the RSI for the last a single of trading hit 41.74, and the three-weeks RSI is set at 43.84 for T2 Biosystems Inc. [TTOO]. The present Moving Average for the last 50 days of trading for this stock 0.1536, while it was recorded at 0.1582 for the last single week of trading, and 0.3744 for the last 200 days.

Insight into T2 Biosystems Inc. Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and T2 Biosystems Inc. [TTOO] shares currently have an operating margin of -153.16 and a Gross Margin at +26.21. T2 Biosystems Inc.’s Net Margin is presently recorded at -175.50.

T2 Biosystems Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.40 and a Current Ratio set at 1.90.

T2 Biosystems Inc. [TTOO] Insider Position Details

There are presently around $3 million, or 5.50% of TTOO stock, in the hands of institutional investors. The top three institutional holders of TTOO stocks are: VANGUARD GROUP INC with ownership of 9,088,832, which is approximately 80.835% of the company’s market cap and around 0.50% of the total institutional ownership; BLACKROCK INC., holding 2,566,595 shares of the stock with an approximate value of $0.34 million in TTOO stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $0.2 million in TTOO stock with ownership of nearly -2.697% of the company’s market capitalization.

13 institutional holders increased their position in T2 Biosystems Inc. [NASDAQ:TTOO] by around 4,839,252 shares. Additionally, 29 investors decreased positions by around 1,064,610 shares, while 35 investors held positions by with 13,098,381 shares. The mentioned changes placed institutional holdings at 19,002,243 shares, according to the latest SEC report filing. TTOO stock had 4 new institutional investments in for a total of 190,326 shares, while 11 institutional investors sold positions of 320,605 shares during the same period.


Please enter your comment!
Please enter your name here